Showing results (151-160 of 281) with videos related to

Sort By:
Pageof 29
Pharmacogenomics|February 5, 2008
Pharmacogenetically relevant polymorphisms in PortugalE Oliveira, S Marsh, D J van Booven, et al.
International Journal of Oncology|February 15, 2001
Analysis of uracil DNA glycosylase in human colorectal cancerC Dusseau, G I Murray, R A Keenan, et al.
Human Molecular Genetics|February 5, 1999
Thiopurine methyltransferase alleles in British and Ghanaian populationsM M Ameyaw, E S Collie-Duguid, R H Powrie, et al.
European Journal of Cancer (Oxford, England : 1990)|January 20, 1999
Autoregulation of 5-fluorouracil metabolismH L McLeod, J Sludden, S C Hardy, et al.
British Journal of Cancer|March 20, 2003
CYP3A4 and VDR gene polymorphisms and the risk of prostate cancer in men with benign prostate hyperplasiaM T Tayeb, C Clark, N E Haites, et al.
Journal of the National Cancer Institute|December 2, 1999
Mercaptopurine therapy intolerance and heterozygosity at the thiopurine S-methyltransferase gene locusM V Relling, M L Hancock, G K Rivera, et al.
Seminars in Oncology|February 1, 1993
Clinical pharmacokinetics and pharmacodynamics of anticancer drugs in childrenJ H Rodman, M V Relling, C F Stewart, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 1999
Phase I targeted systemic exposure study of paclitaxel in children with refractory acute leukemiasM H Woo, M V Relling, D S Sonnichsen, et al.
The Pharmacogenomics Journal|June 6, 2012
Functional characterization of ABCC2 promoter polymorphisms and allele-specific expressionT D Nguyen, S Markova, W Liu, et al.
Lancet (London, England)|November 9, 2000
Adverse effect of anticonvulsants on efficacy of chemotherapy for acute lymphoblastic leukaemiaM V Relling, C H Pui, J T Sandlund, et al.
Pageof 29